                         SEQUENCE LISTING

<110>  OVID THERAPEUTICS, INC.
       DURING, Matthew
 
<120>  USE OF MIR-92A OR MIR-145 IN THE TREATMENT OF ANGELMAN SYNDROME

<130>  2262-63 PCT

<150>  US 62/684,774
<151>  2018-06-14

<160>  2     

<170>  PatentIn version 3.5

<210>  1
<211>  22
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  Synthetic: microRNA-92a-3p

<400>  1
uauugcacuu gucccggccu gu                                                22


<210>  2
<211>  23
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  Synthetic: microRNA-145-5p

<400>  2
guccaguuuu cccaggaauc ccu                                               23


